PSA is dead, long live PSA.

PSA is dead, long live PSA.

Opis bibliograficzny
Główni autorzy:	Vickers, A, Lilja, H
Format:	Journal article
Język:	English
Wydane:	2012

Podobne zapisy

Prostate cancer: estimating the benefits of PSA screening.
od: Vickers, A, i wsp.
Wydane: (2009)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
od: Sävblom, C, i wsp.
Wydane: (2005)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
od: Blijenberg, BG, i wsp.
Wydane: (2003)

We need a better marker for prostate cancer. How about renaming PSA?
od: Vickers, A, i wsp.
Wydane: (2012)

Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer.
od: Lilja, H
Wydane: (2001)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
od: Sävblom, C, i wsp.
Wydane: (2009)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
od: Törnblom, M, i wsp.
Wydane: (2001)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
od: Emerson P. Gregorio, i wsp.
Wydane: (2007-04-01)

Serbest PSA/Total pSA Oranının Günlük Varyasyonu
od: Fatma Özdemir, i wsp.
Wydane: (2011-06-01)

Total PSA and free PSA in patients with severe liver dysfunction
od: Rama Devi Mittal, i wsp.
Wydane: (2003-01-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
od: Mohammad Yazdani, i wsp.
Wydane: (2013-10-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
od: Amit M. Algotar PhD, MBBS, i wsp.
Wydane: (2011-05-01)

Review on the Application of Living PSA in Nuclear Power
od: Min Zhang, i wsp.
Wydane: (2024-11-01)

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
od: O'Brien, M, i wsp.
Wydane: (2009)

Genetic correction of PSA values using sequence variants associated with PSA levels.
od: Gudmundsson, J, i wsp.
Wydane: (2010)

Can PSA velocity predict risk of death in men with prostate cancer?
od: Lilja, H, i wsp.
Wydane: (2007)

Controversies in PSA screening
od: O'Sullivan, J
Wydane: (2017)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
od: Daniel Simanjuntak, i wsp.
Wydane: (2016-03-01)

Study of Serum Total PSA and Free PSA as an Oncological Marker in Breast Tumour
od: Elteza Tahjiba Jahir, i wsp.
Wydane: (2017-03-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
od: Tsung-Hsin Chang, i wsp.
Wydane: (2020-10-01)

Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
od: Ulmert, D, i wsp.
Wydane: (2008)

Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
od: Nurmikko, P, i wsp.
Wydane: (2000)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
od: Strittmatter F, i wsp.
Wydane: (2011-10-01)

Free PSA: A better molecular marker than total PSA for breast cancer
od: Rachita Nanda
Wydane: (2014-10-01)

Erratum: Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level (British Journal of Urology International 87 (638-642))
od: Törnblom, M, i wsp.
Wydane: (2001)

Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
od: Kurek, R, i wsp.
Wydane: (2003)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
od: Steuber, T, i wsp.
Wydane: (2006)

Utility of PSA isoform-[-2] proPSA (p2PSA) and prostate health index in the diagnosis of prostate cancer: A study in Indian population
od: Govinda Raju NL, i wsp.
Wydane: (2022-01-01)

Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(₁₄₅) or Lys(₁₄₆) from fPSA without internal cleavages at Lys(₁₄₅) or Lys(₁₄₆).
od: Peltola, M, i wsp.
Wydane: (2011)

PSA Kuasai Sirkit enam
od: Harian Metro,
Wydane: (2012)

2023 PSA ANNUAL MEETING
Wydane: (2023-12-01)

PSA screening - for whom and when?
od: Peter Albers
Wydane: (2019-01-01)

Printonix PSA : P5215 /
od: Universiti Teknologi Malaysia Perpustakaan 3383, i wsp.
Wydane: (2000)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
od: McGagh, D, i wsp.
Wydane: (2020)

Free PSA estimation substituted by calculation where total PSA value is up to 4 ng/ml
od: M Dhumne, i wsp.
Wydane: (2006-01-01)

Testing new PSA subforms to enhance the accuracy of predicting cancer risk and disease outcome in prostate cancer.
od: Lilja, H
Wydane: (2008)

Age-specific reference intervals for Prostate-Specific-Antigen (PSA), its isoform-[-2] pro-PSA (p2PSA) and prostate health index in Indian males
od: Govinda Raju NL, i wsp.
Wydane: (2024-04-01)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml−1
od: Ma-Ping Huang, i wsp.
Wydane: (2023-01-01)

Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.
od: Giwercman, Y, i wsp.
Wydane: (2004)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
od: Mehmet Coşkun, i wsp.
Wydane: (2021-02-01)